• SENSEX 77,414.92
    -191.51 (--0.25%)
  • BANKNIFTY 51,564.85
    -11.00 (--0.02%)
  • Hind.Aeronautics
    4,294.00 5,675.00(%)
  • Zomato Ltd
    200.50 146.85(%)
  • Aster DM Health.
    504.00 558.30(%)
  • Reliance Industr
    1,269.05 1,156.00(%)
  • Tata Motors
    684.90 1,179.05(%)
  • Jio Financial
    232.25 394.70(%)
  • Mazagon Dock
    2,635.55 920.48(%)
  • Vodafone Idea
    6.77 6.60(%)
  • HDFC Bank
    1,836.40 1,880.00(%)
  • Suzlon Energy
    56.40 37.95(%)
  • M & M
    2,635.10 1,872.45(%)
  • IDFC First Bank
    54.63 52.60(%)
  • Dixon Technolog.
    13,019.00 7,100.05(%)
  • I R F C
    123.65 108.05(%)
  • Bharat Electron
    306.50 340.35(%)
  • Adani Energy Sol
    863.60 588.25(%)
  • Asian Paints
    2,322.35 2,125.00(%)
  • Reliance Power
    44.75 54.25(%)
  • Hindustan Copper
    218.75 195.35(%)
  • IndusInd Bank
    643.70 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mangalam Drugs and Organics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20249.0
  • ISIN : INE584F01014
74.30 -1 (-1.04%)
  • As on 31 Mar 2025 (EOD)

  • Today’s Low

    74.05

  • Today’s High

    76.72

  • Open

    76.01

  • Perv Close

    75.08

  • 52W Low

    74.05

  • 52W High

    144.99

Key Indicators

  • P/E(TTM)

    11.38

  • Mar.Cap (₹Cr.)

    117.60

  • Div & Yield %

    0.00

  • Book Value(₹)

    93.15

  • Debt-Equity Ratio

    -1.04

  • AGM Date

    28-Mar-2025

  • EPS

    6.52

  • P/E Ratio

    11.38

Financials Ratios

  • Debt-Equity Ratio

    0.78

  • Mar.Cap (₹Cr.)

    117.60

  • RONW (%)

    -6.68

  • ROCE (%)

    1.16

Score Board

  • Equity (₹ in Cr.)

    15.83

  • BV (₹)

    93.10

  • Sales( ₹ in Cr.)

    368.59

  • NP (in Cr.)

    -9.00

  • NP Var(%)

    -808.0

  • Div%

    0.0

  • CPS (₹)

    3.60

  • EPS (₹)

    -5.70

  • Traded Value (₹ in Lakhs)

    117.48

  • 52 Week High

    144.99

  • 52 Week Low

    74.05

  • Price BSE

    74.0

  • Price NSE

    74.00

  • Market Capital( in Cr.)

    117.48

  • P/C Ratio

    20.80

  • P/E Ratio

    -13.00

  • Price Vs.BV

    -5.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 368.59 372.25 451.07 379.98 313.13 258.81
Excise Duty 364.55 349.58 424.96 379.80 309.66 251.60
Net Sales 368.59 372.25 451.07 379.98 313.13 258.81
Other Income 0.10 0.44 0.09 4.72 1.18 0.32
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 368.69 372.69 451.16 384.70 283.53 227.90
EXPENDITURE :
Raw Materials 364.55 349.58 424.96 379.80 309.66 251.60
Power & Fuel Cost 364.55 349.58 424.96 379.80 309.66 251.60
Employee Cost 39.07 34.61 37.25 29.88 26.04 25.82
Other Manufacturing Expenses 12.76 12.71 9.67 4.42 2.76 0.32
Selling & Administrative Expenses 13.10 11.60 13.64 16.19 14.36 15.85
Miscellaneous Expenses 12.76 12.71 9.67 4.42 2.76 0.32
Less : Pre-operative Expenses Capitalised :
Total Expenditure 379.75 370.47 423.42 345.18 277.28 233.63
Operating Profit 41.75 37.16 34.82 24.23 20.15 22.59
Interest 13.92 12.96 11.16 9.33 10.40 8.65
Gross Profit -11.06 2.21 27.73 39.52 6.25 -5.74
Depreciation 14.63 10.99 10.25 9.18 8.22 7.09
Profit Before Tax -11.06 2.21 27.73 39.52 6.25 -5.74
Tax 0.00 0.39 8.76 9.27 1.10 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.20 0.97 -0.73 2.28 -2.05 2.29
Reported Net Profit -9.05 1.27 19.66 27.97 8.25 -8.03
Extraordinary Items -11.06 2.21 27.73 39.52 6.25 -5.74
Adjusted Net Profit -9.05 1.27 19.66 27.97 8.25 -8.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -9.05 1.27 19.66 27.97 8.25 -8.03
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -5.72 0.80 12.42 17.67 5.21 -5.07
Book Value 0.00 0.00 0.00 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 0.00 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    50.30%

  • Public Share Holding

    49.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,951,698 31.28 4,951,698 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,010,348 19.02 3,010,348 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,962,046 50.30 7,962,046 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 306 0.00 306 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 17,505 0.11 17,505 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 17,811 0.11 17,811 3
2] Non Institution
Bodies Corporate 336,107 2.12 336,107 78
Clearing Members 2,475 0.02 2,475 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 158,860 1.00 158,860 334
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 262,943 1.66 262,943 305
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,243,318 14.17 2,243,318 45
Individuals holding nominal share capital up to Rs. 1 lakh 4,844,688 30.61 4,844,678 18,893
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,848,391 49.58 7,848,381 19,658
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,828,248 100.00 15,828,238 19,679

Company Background

Mangalam Drugs and Organics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mangalam Drugs and Organics Ltd
  • BSE Code : 20249.0
  • ISIN : INE584F01014

  • Incorporation Year

    1972

  • Registered Office

    3rd Floor Rupam Building
    239 P D Mello Road, Mumbai,
    Maharashtra-400001

  • Telephone

    91-22-22616200/6300/8787

  • FAX

    91-22-26190900

  • Chairman

    Govardhan M Dhoot

  • Managing Director

    Govardhan M Dhoot

  • Company Secretary

    Anuradha Pandey

  • Auditor

    V S Somani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Mangalam Drugs and Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mangalam Drugs 74.22 368.69 368.59 11.38 1.16
Abbott India 30,730.65 6,097.18 5,848.91 48.94 44.71
Astrazeneca Phar 8,606.35 1,330.33 1,295.53 221.87 33.26
P & G Health Ltd 5,142.30 1,166.89 1,151.26 36.08 39.76
Glaxosmi. Pharma 2,877.30 3,530.73 3,407.25 57.21 44.44
Cipla 1,441.70 17,645.00 16,574.34 24.72 20.10
Amrutanjan Healt 644.85 437.58 421.23 37.80 20.84
Guj. Themis Bio. 281.50 174.19 169.82 58.28 44.82
Fermenta Biotec. 273.55 315.24 307.09 25.93 4.10
Bliss GVS Pharma 117.55 638.96 605.46 26.90 11.19
Ambalal Sarabhai 35.05 11.70 3.81 14.98 1.92